MRVI vs SYF · rev $117.3M vs rev $11.19B
Maravai Lifesciences Holdings Inc (MRVI) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
SYF (SYF) common stock.
Latest reported MRVI revenue for 2026-06-30 was $117.3M. Net income was -$16.1M. Revenue was up 78.1% from 2026-03-31 to 2026-06-30. MRVI currently screens at market cap $1.93B.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
MRVI currently screens at market cap $1.93B. SYF currently screens at market cap $0.
Not investment advice. Open the MRVI and SYF stock pages for the full models.
Not investment advice.